Algernon Pharmaceuticals Inc (AGNPF)

[Lowersioux5]

Well done sir. It's too bad you had to waste your time breaking it down. Especially to someone with "expertise" and has been here since Day 1.

Hemingway.. I think we sit in a "comfortable" position at the moment, considering there remains no significantly effective treatment, and especially, since Dec 15 (the day that pushed the previous mentioned over the cliff) we have added the major potential endpoint of reducing fibrosis.

But!!..If I were to "devil's advocate" the current status, a real issue in my opinion is how can the company (Algernon) STUDYING the drug that THEY are submitting for FDA approval not have known to include an arm with a DOUBLE DOSE?

I mean, c'mon man, the "double dose" is still half of the dose prescribed in Japan for Vertigo..correct? Not sure on that one.. but anyway, if even the FDA was confident enough in Ifenprodil's safety history to suggest a double-dose, wouldn't an even higher dose be considered?.

Just seems odd that MW didn't have that figured out. If not for the FDA stepping in, the interim data would've been a total flop.

It's like the FDA had more sense then our guys..headscratcher.

On the bright side.. if there's one entity we want on our side.. it's the people ultimately deciding our fate.